# A Study to Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US

> **NCT07107373** · — · ACTIVE_NOT_RECRUITING · sponsor: **Bristol-Myers Squibb** · enrollment: 150 (estimated)

## Conditions studied

- Obstructive Hypertrophic Cardiomyopathy (oHCM)

## Interventions

- **DRUG:** Mavacamten

## Key facts

- **NCT ID:** NCT07107373
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-12-22
- **Primary completion:** 2024-07-26
- **Final completion:** 2025-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07107373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07107373, "A Study to Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT07107373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*